ARCHIVES

Pazdur: Registration Trials Run By Groups Need Same Rigor As Industry Trials

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

Cuts From NCI Budget total $38 Million; Prevention Gets $21 Million Increase

January 24, 1992

Funding Opportunities: RFA Available: Teams For Molecular Target Assessment

November 26, 1999

Wyngaarden Helps Make Case For Facilities Funding, Reveals Plan For New NIH Building

April 15, 1988

Two Drugs Slow Progress Of Metastatic Prostate Cancer

June 29, 2001

Georgetown Sponsors Oncology Agent Development Meeting

March 21, 2003

Laertrile Clinical Study Provides Solid Evidence: It Is Useless

May 8, 1981